{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:55:12Z","timestamp":1788872112176,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["276745"],"award-info":[{"award-number":["276745"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["D.lgs 502\/92"],"award-info":[{"award-number":["D.lgs 502\/92"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["10-2012-204"],"award-info":[{"award-number":["10-2012-204"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clim.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T02:03:21Z","timestamp":1418436201000},"page":"98-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner"],"prefix":"10.1016","volume":"156","author":[{"given":"Georgia","family":"Fousteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Jofra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Fonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Kuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Iannacone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2014.12.002_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-immunol-032713-120249","article-title":"Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease","volume":"32","author":"Bottini","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.clim.2013.10.006","article-title":"Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity","volume":"149","author":"Fousteri","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2014.12.002_bb0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2337\/db12-0929","article-title":"PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant","volume":"62","author":"Zheng","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.12.002_bb0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.1203380","article-title":"Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice","volume":"191","author":"Yeh","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.clim.2014.12.002_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","article-title":"Ablation of \u201ctolerance\u201d and induction of diabetes by virus infection in viral antigen transgenic mice","volume":"65","author":"Ohashi","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.clim.2014.12.002_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni0209-129","article-title":"Animal models of human type 1 diabetes","volume":"10","author":"von Herrath","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4049\/jimmunol.164.1.208","article-title":"Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers","volume":"164","author":"Slifka","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.178.2.589","article-title":"Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice","volume":"178","author":"Laufer","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.12.002_bb0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.clim.2014.12.002_bb0060","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/diabetes.49.11.1801","article-title":"Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes","volume":"49","author":"Seewaldt","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.12.002_bb0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1176","article-title":"Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease","volume":"11","author":"Lang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2014.12.002_bb0070","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI200113915","article-title":"Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes","volume":"108","author":"Holz","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2014.12.002_bb0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.185.3.531","article-title":"Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus","volume":"185","author":"von Herrath","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.12.002_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mt.2009.197","article-title":"Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3\/GAD65 combination therapy in new-onset type 1 diabetes","volume":"18","author":"Bresson","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2014.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI27191","article-title":"Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs","volume":"116","author":"Bresson","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2014.12.002_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2014.05.006","article-title":"Regulatory T cells control diabetes without compromising acute anti-viral defense","volume":"153","author":"Baca Jones","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.immuni.2013.06.013","article-title":"The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity","volume":"39","author":"Wang","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.12.002_bb0100","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1172\/JCI66963","article-title":"A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models","volume":"123","author":"Dai","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2014.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4049\/jimmunol.1302418","article-title":"PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells","volume":"192","author":"Maine","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003365","article-title":"Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function","volume":"5","author":"Brownlie","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.clim.2014.12.002_bb0115","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.4049\/jimmunol.1200150","article-title":"PTPN22 alters the development of regulatory T cells in the thymus","volume":"188","author":"Maine","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.1092138","article-title":"PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector\/memory T cells","volume":"303","author":"Hasegawa","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.clim.2014.12.002_bb0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ni.2958","article-title":"The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals","volume":"15","author":"Salmond","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2008.12.001","article-title":"CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes","volume":"32","author":"Fousteri","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2014.12.002_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.clim.2014.12.002_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model","volume":"1","author":"von Herrath","year":"1994","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.clim.2014.12.002_bb0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.12.002_bb0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host-microorganism interactions (*)","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0155","first-page":"83","article-title":"Biology and pathogenesis of lymphocytic choriomeningitis virus infection","volume":"263","author":"Oldstone","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0160","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.2337\/diabetes.50.12.2700","article-title":"Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain","volume":"50","author":"von Herrath","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.12.002_bb0165","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1155209","article-title":"Coordination of early protective immunity to viral infection by regulatory T cells","volume":"320","author":"Lund","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.clim.2014.12.002_bb0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1227049","article-title":"Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory","volume":"338","author":"Pace","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.clim.2014.12.002_bb0175","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.4049\/jimmunol.1000423","article-title":"Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection","volume":"185","author":"Fulton","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.12.002_bb0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/viro.1997.8934","article-title":"Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice","volume":"240","author":"van der Most","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.clim.2014.12.002_bb0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:45:19Z","timestamp":1779306319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661614002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1521661614002691"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2014.12.002","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}